HIV Infection

Infectious Disease·MeSH: HIV Infections

Prevalence

380.0 / 100K

Incidence

12.0 / 100K/yr

29 drugs in development·12 companies·12 clinical trials

Drug Pipeline by Phase

Phase 1(20)
DrugCompany
10-1074ImmunityBio, Inc. (IBRX)
3M-05-AFValneva SE (VALN)
3M-052-AFValneva SE (VALN)
3M-052-AFDYNAVAX TECHNOLOGIES CORP (DVAX)
9vHPV Vaccine plus BCG Vaccine Mix for percutaneous useDesign Therapeutics, Inc. (DSGN)
AlumDYNAVAX TECHNOLOGIES CORP (DVAX)
Aluminum hydroxide suspensionValneva SE (VALN)
BG505 SOSIP.664 gp140DYNAVAX TECHNOLOGIES CORP (DVAX)
CD40.HIVRI.EnvCrinetics Pharmaceuticals, Inc. (CRNX)
CH505 TF chTrimerValneva SE (VALN)
GLA-LSQDYNAVAX TECHNOLOGIES CORP (DVAX)
Hiltonol Poly-ICLC-adjuvantCrinetics Pharmaceuticals, Inc. (CRNX)
jl18008Day One Biopharmaceuticals, Inc. (DAWN)
MK-4646Merck & Co., Inc. (MRK)
mRNA-1645-CoreG28v2Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-eODGT8Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-N332GT5Cidara Therapeutics, Inc. (CDTX)
sar441236OPKO HEALTH, INC. (OPK)
Trimer 4571DYNAVAX TECHNOLOGIES CORP (DVAX)
VRC07-523LSImmunityBio, Inc. (IBRX)

Compare drugs

HEPLISAV-B vs ARTHEPLISAV-B vs DOR/ISLHEPLISAV-B vs ENGERIX-B

Frequently asked questions

How many drugs are in development for HIV Infection?

BioSniper tracks 29 drugs in development for HIV Infection across 12 companies.

How many clinical trials target HIV Infection?

There are 12 clinical trials targeting HIV Infection tracked by BioSniper.

What is the prevalence of HIV Infection?

The estimated prevalence of HIV Infection is approximately 380.0 per 100,000 population.

Deep-dive into HIV Infection

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    HIV Infection — Drugs in Development & Clinical Trials | BioSniper